Physician profile
Martha E Oates
NPI 1750827796
$2,840.87
in general payments reported to CMS, 2019-2025
16 companies · $1,024 in 2025
The $1,024 reported for 2025 was more than what 87% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.22 · 2022: $129 · 2023: $296 · 2024: $1,363 · 2025: $1,024.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,682.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braeburn INC. | $650.55 | 2023-2025 | Brixadi |
| Gilead Sciences, INC. | $650.22 | 2022-2025 | Epclusa |
| Viiv Healthcare Company | $271.91 | 2021-2025 | Apretude, Cabenuva, Dovato |
| Abbvie INC. | $228.75 | 2023-2025 | |
| Exact Sciences Corporation | $228.53 | 2024-2025 | Cologuard Collection Kit |
| Indivior INC. | $224.13 | 2022-2025 | Sublocade |
| Merck Sharp & Dohme LLC | $139.50 | 2023-2025 | Pifeltro, Delstrigo, Dificid |
| Sanofi-Aventis U.S. LLC | $124.99 | 2025 | |
| Theratechnologies INC. | $81.03 | 2023-2025 | Egrifta, Trogarzo |
| Alkermes, INC. | $80.51 | 2021-2025 | Vivitrol, Vivitrol |
| Janssen Pharmaceuticals, INC | $57.20 | 2023-2024 | Spravato |
| Antares Pharma, INC. | $33.19 | 2024 | Xyosted |
| Emd Serono, INC. | $26.02 | 2022 | |
| Novo Nordisk INC | $16.19 | 2024 | Rybelsus, Ozempic |
| Janssen Biotech, INC. | $15.80 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $12.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martha Oates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.